
The US Food and Drug Administration in December approved the use of Tamiflu (oseltamivir phosphate) for preventing seasonal influenza in children 1 to 12 years old. Tamiflu's labeled use had previously been for prevention and treatment of flu in children 13 years and older, as well as in adults.